COX-2 Inhibition in Schizophrenia and Major Depression

E-ISSN： 1873-4286|14|14|1452-1465

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.14, 2008-05, pp. : 1452-1465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the field of COX-2 inhibition

By Delarge Jacques Dogné Jean-Michel Julémont Fabien Leval Xavier de Pirotte Bernard Sanna Vanna

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 969-989

Informa Healthcare

Access to resources Recommend Favorite

Mucosal Repair and COX-2 Inhibition

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2207-2211

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Approach for COX-2 Inhibition

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 603-615

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibitors as adjunctive therapy in schizophrenia

By Müller Norbert Strassnig Martin Schwarz Markus J Ulmschneider Markus Riedel Michael

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Cancer and Cyclooxygenase-2 (COX-2) Inhibition

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 627-634

Bentham Science Publishers

Access to resources Recommend Favorite